Aug 17, 2021
Rocket Relaunches Gene Therapy Program as FDA Lifts Clinical Hold
Posted by Jason Blain in category: biotech/medical
New gene therapy in trials for Danon disease.
“The only available treatment option for Danon disease is a heart transplant. Currently, there are no specific therapies available for the treatment of Danon disease.”
The U.S. Food and Drug Administration (FDA) lifted the clinical hold it placed on Rocket Pharmaceuticals’ experimental gene therapy for Danon disease. Patient enrollment in the Phase I study will resume, the company announced this morning.
Continue reading “Rocket Relaunches Gene Therapy Program as FDA Lifts Clinical Hold” »